These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49 related articles for article (PubMed ID: 9262355)
1. Possible mechanism of action of AE0047, a calcium antagonist, on triglyceride metabolism. Hayashi K; Gohda M; Matzno S; Kubo Y; Kido H; Yamauchi T; Nakamura N J Pharmacol Exp Ther; 1997 Aug; 282(2):882-90. PubMed ID: 9262355 [TBL] [Abstract][Full Text] [Related]
2. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo. Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467 [TBL] [Abstract][Full Text] [Related]
3. Omega-3 fatty acid containing diets decrease plasma triglyceride concentrations in mice by reducing endogenous triglyceride synthesis and enhancing the blood clearance of triglyceride-rich particles. Qi K; Fan C; Jiang J; Zhu H; Jiao H; Meng Q; Deckelbaum RJ Clin Nutr; 2008 Jun; 27(3):424-30. PubMed ID: 18362042 [TBL] [Abstract][Full Text] [Related]
4. [Effects of angiotensin II type 1 receptor blocker on triglyceride metabolism in the liver: experiment with Zucker fatty rats]. Ran JM; Lao GC; Xu G; Xie B; Zhang Y; Liu W; Feng Q; Guo J Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(22):1557-61. PubMed ID: 18956640 [TBL] [Abstract][Full Text] [Related]
5. Enhanced cellular uptake of remnant high-density lipoprotein particles: a mechanism for high-density lipoprotein lowering in insulin resistance and hypertriglyceridemia. Xiao C; Watanabe T; Zhang Y; Trigatti B; Szeto L; Connelly PW; Marcovina S; Vaisar T; Heinecke JW; Lewis GF Circ Res; 2008 Jul; 103(2):159-66. PubMed ID: 18556574 [TBL] [Abstract][Full Text] [Related]
6. 11beta-HSD1 inhibition improves triglyceridemia through reduced liver VLDL secretion and partitions lipids toward oxidative tissues. Berthiaume M; Laplante M; Festuccia WT; Cianflone K; Turcotte LP; Joanisse DR; Olivecrona G; Thieringer R; Deshaies Y Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1045-52. PubMed ID: 17666487 [TBL] [Abstract][Full Text] [Related]
8. Cholesteryl ester transfer protein (CETP) increases postprandial triglyceridaemia and delays triacylglycerol plasma clearance in transgenic mice. Salerno AG; Patrício PR; Berti JA; Oliveira HC Biochem J; 2009 May; 419(3):629-34. PubMed ID: 19191759 [TBL] [Abstract][Full Text] [Related]
9. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia. Julius U Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice. Lettéron P; Sutton A; Mansouri A; Fromenty B; Pessayre D Hepatology; 2003 Jul; 38(1):133-40. PubMed ID: 12829995 [TBL] [Abstract][Full Text] [Related]
11. Increased binding of LDL and VLDL to apo B,E receptors of hepatic plasma membrane of rats treated with Fibernat. Venkatesan N; Devaraj SN; Devaraj H Eur J Nutr; 2003 Oct; 42(5):262-71. PubMed ID: 14569407 [TBL] [Abstract][Full Text] [Related]
12. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats. Stanely Mainzen Prince P; Kannan NK J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661 [TBL] [Abstract][Full Text] [Related]
13. Possible mechanism for the anti-atherosclerotic action of the calcium channel blocker AE0047 in cholesterol-fed rabbits. Hayashi K; Imada T; Yamauchi T; Kido H; Shinyama H; Matzno S; Nakamura N; Kagitani Y Clin Exp Pharmacol Physiol; 1998 Jan; 25(1):17-25. PubMed ID: 9493553 [TBL] [Abstract][Full Text] [Related]
14. Ritonavir impairs lipoprotein lipase-mediated lipolysis and decreases uptake of fatty acids in adipose tissue. den Boer MA; Berbée JF; Reiss P; van der Valk M; Voshol PJ; Kuipers F; Havekes LM; Rensen PC; Romijn JA Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):124-9. PubMed ID: 16269669 [TBL] [Abstract][Full Text] [Related]
15. Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies. Hayashi T; Hirano T; Yamamoto T; Ito Y; Adachi M Metabolism; 2006 Jul; 55(7):879-84. PubMed ID: 16784958 [TBL] [Abstract][Full Text] [Related]
16. Essential fatty acid deficiency in mice is associated with hepatic steatosis and secretion of large VLDL particles. Werner A; Havinga R; Bos T; Bloks VW; Kuipers F; Verkade HJ Am J Physiol Gastrointest Liver Physiol; 2005 Jun; 288(6):G1150-8. PubMed ID: 15662048 [TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E*3-Leiden transgenic mice as a test model for hypolipidaemic drugs. van Vlijmen BJ; Pearce NJ; Bergö M; Staels B; Yates JW; Gribble AD; Bond BC; Hofker MH; Havekes LM; Groot PH Arzneimittelforschung; 1998 Apr; 48(4):396-402. PubMed ID: 9608883 [TBL] [Abstract][Full Text] [Related]
18. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism? Battula SB; Fitzsimons O; Moreno S; Owens D; Collins P; Johnson A; Tomkin GH Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025 [TBL] [Abstract][Full Text] [Related]
19. Estimated liver weight is directly related to hepatic very low-density lipoprotein-triglyceride secretion rate in men. Tsekouras YE; Magkos F; Kavouras SA; Panagiotakos DB; Sidossis LS Eur J Clin Invest; 2008 Sep; 38(9):656-62. PubMed ID: 18837742 [TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of AE0047, a new dihydropyridine Ca(2+) channel blocker, on renal nerve stimulation-induced renal actions in anesthetized dogs. Yamasaki T; Ohmagari M; Tamai I; Hayashi K; Matsumura Y J Pharmacol Exp Ther; 2000 Jun; 293(3):1040-7. PubMed ID: 10869409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]